Literature DB >> 20938390

Transfusion-related acute lung injury after transfusion of maternal blood: a case-control study.

Nancy Dunbar1, Margaret Cooke, Mohammad Diab, Pearl Toy.   

Abstract

STUDY
DESIGN: This is a single-center retrospective case-control study of 7 transfusion-related acute lung injury (TRALI) cases and 28 controls in the pediatric spinal surgery population.
OBJECTIVE: To determine the association between maternal transfusion and risk of TRALI in pediatric spinal surgery patients. SUMMARY OF BACKGROUND DATA: Previous studies support a "2-hit" model for the pathogenesis of TRALI-activation and sequestration of neutrophils in the pulmonary vasculature followed by transfusion of a biologic response modifier such as antileukocyte antibodies. Maternal donation of blood products is a potential risk factor for TRALI because of the development of antileukocyte antibodies during pregnancy. Until now there have been no studies specifically addressing the risk of TRALI following maternal transfusions.
METHODS: This is a retrospective case-control study of 7 TRALI cases with 4 controls per case, matched by strata for volume of plasma transfused. All cases identified by the Transfusion Biology and Medicine Specialized Center of Clinically Oriented Research with a TRALI diagnosis were eligible for inclusion. Electronic medical records and operative notes were reviewed to obtain demographic data, diagnosis, surgical approach, and number of spine levels for each operation.
RESULTS: An increased prevalence of maternal blood transfusion was found among the TRALI cases compared with the control cases: 43% (3 of 7) versus 7% (2 of 28), P = 0.044. There were otherwise no statistical differences between the groups, including age, gender, surgical approach, number of spinal levels, or type of blood product transfused.
CONCLUSION: Pediatric patients undergoing spinal surgery may be at increased risk for the development of TRALI following the transfusion of maternal blood products. Accordingly, we recommend that directed donation of maternal blood products should be avoided in this population. This study also found that TRALI may be underrecognized and underreported to the transfusion service.

Entities:  

Mesh:

Year:  2010        PMID: 20938390      PMCID: PMC2964398          DOI: 10.1097/BRS.0b013e3181e3dad2

Source DB:  PubMed          Journal:  Spine (Phila Pa 1976)        ISSN: 0362-2436            Impact factor:   3.468


  25 in total

Review 1.  Fatalities caused by TRALI.

Authors:  Leslie Holness; Maureen A Knippen; Lois Simmons; Peter A Lachenbruch
Journal:  Transfus Med Rev       Date:  2004-07

2.  Leukoagglutination with interstitial pulmonary edema. A complication of donor-specific transfusion.

Authors:  D A Campbell; R D Swartz; J A Waskerwitz; R F Haines; J G Turcotte
Journal:  Transplantation       Date:  1982-11       Impact factor: 4.939

3.  Fatal pulmonary hypersensitivity reaction to HL-A incompatible blood transfusion:report of a case and review of the literature.

Authors:  C F Wolf; V C Canale
Journal:  Transfusion       Date:  1976 Mar-Apr       Impact factor: 3.157

4.  Transfusion reactions in donor-specific blood transfusion patients resulting from transfused maternal antibody.

Authors:  N E Goeken; J A Schulak; D D Nghiem; L B Knox; L S Reynolds; R J Corry
Journal:  Transplantation       Date:  1984-09       Impact factor: 4.939

5.  Transfusion-related acute lung injury resulting from designated blood transfusion between mother and child: a report of two cases.

Authors:  Xu Yang; Shahid Ahmed; Visalam Chandrasekaran
Journal:  Am J Clin Pathol       Date:  2004-04       Impact factor: 2.493

6.  Management of transfusion-related acute lung injury with extracorporeal cardiopulmonary support in a four-year-old child.

Authors:  S M Nouraei; J P Wallis; D Bolton; A Hasan
Journal:  Br J Anaesth       Date:  2003-08       Impact factor: 9.166

7.  Biological mothers may be dangerous blood donors for their neonates.

Authors:  C Elbert; R G Strauss; F Barrett; N E Goeken; B Pittner; D Cordle
Journal:  Acta Haematol       Date:  1991       Impact factor: 2.195

8.  Transfusion-related acute lung injury: epidemiology and a prospective analysis of etiologic factors.

Authors:  Christopher C Silliman; Lynn K Boshkov; Zahra Mehdizadehkashi; David J Elzi; William O Dickey; Linda Podlosky; Gwen Clarke; Daniel R Ambruso
Journal:  Blood       Date:  2002-09-05       Impact factor: 22.113

9.  Platelet depletion and aspirin treatment protect mice in a two-event model of transfusion-related acute lung injury.

Authors:  Mark R Looney; John X Nguyen; Yongmei Hu; Jessica A Van Ziffle; Clifford A Lowell; Michael A Matthay
Journal:  J Clin Invest       Date:  2009-10-05       Impact factor: 14.808

10.  Diagnostic and pathogenetic considerations in transfusion-related acute lung injury.

Authors:  M A Popovsky; S B Moore
Journal:  Transfusion       Date:  1985 Nov-Dec       Impact factor: 3.157

View more
  3 in total

1.  A Clinical Trial to Detect Subclinical Transfusion-induced Lung Injury during Surgery.

Authors:  John R Feiner; Michael A Gropper; Pearl Toy; Jeremy Lieberman; Jenifer Twiford; Richard B Weiskopf
Journal:  Anesthesiology       Date:  2015-07       Impact factor: 7.892

2.  Recommendations on RBC Transfusions in Critically Ill Children With Acute Respiratory Failure From the Pediatric Critical Care Transfusion and Anemia Expertise Initiative.

Authors:  Pierre Demaret; Guillaume Emeriaud; Nabil E Hassan; Martin C J Kneyber; Stacey L Valentine; Scot T Bateman; Marisa Tucci
Journal:  Pediatr Crit Care Med       Date:  2018-09       Impact factor: 3.624

3.  Transfusion-related Acute Lung Injury: 36 Years of Progress (1985-2021).

Authors:  Pearl Toy; Mark R Looney; Mark Popovsky; Miodrag Palfi; Gösta Berlin; Catherine E Chapman; Paula Bolton-Maggs; Michael A Matthay
Journal:  Ann Am Thorac Soc       Date:  2022-05
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.